Fortrea Holdings (FTRE) Tax Rate (2022 - 2026)
Fortrea Holdings' (FTRE) quarterly Tax Rate came in at 1000.0% in Q2 2026, down 99887.0% on a YoY basis from N/an in Q2 2025, and down 988.5% quarter-over-quarter from 91.87% in Q1 2026.
Analysis
Fortrea Holdings (FTRE) Tax Rate (2022 - 2026) Analysis & Trends
Fortrea Holdings (FTRE) has reported Tax Rate for 5 consecutive years, with 1000.0% the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Tax Rate fell 99887.0% year-over-year to 1000.0%; the trailing twelve-month figure through Jun 2026 stood at 9.51% (down 943.0% YoY), and the FY2025 full-year result was 0.33%, down 160.0% from the prior year.
- Tax Rate fell to 1000.0% in Q2 2026 per FTRE's latest filing, from 91.87% in the prior quarter.
- Across five years, Tax Rate topped out at 48.32% in Q3 2024 and bottomed at 1000.0% in Q2 2026.
- Historically, Tax Rate has averaged 55.89% across 5 years, with a median of 8.71% in 2025.
- The sharpest annual moves came in 2023 and 2026: Tax Rate soared 7501 bps in 2023, then slumped 99887 bps in 2026.
- Over 5 years, Tax Rate stood at 63.86% in 2022, then soared by 117 bps to 11.15% in 2023, then plunged by 88 bps to 1.34% in 2024, then jumped by 552 bps to 8.71% in 2025, then slumped by 11584 bps to 1000.0% in 2026.
- According to Business Quant data, Tax Rate over the past three periods registered 1000.0%, 91.87%, and 8.71% for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.06 Bn | 42.11 Bn | 1.44 Bn | 19.93% |
| 2 | Medpace Holdings | 16.50 Bn | 16.00 Bn | 201.64 Mn | 19.98% |
| 3 | Charles River Laboratories International | 13.77 Bn | 13.62 Bn | 452.07 Mn | 101.43% |
| 4 | Icon | 12.62 Bn | 11.69 Bn | 479.29 Mn | -21.28% |
| 5 | Fortrea Holdings | 1.68 Bn | 1.51 Bn | 139.20 Mn | -1,000.00% |
| 6 | Evotec SE | 661.34 Mn | 235.46 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 442.79 Mn | 358.26 Mn | 18.44 Mn | -0.22% |
| 8 | Champions Oncology | 72.49 Mn | 72.62 Mn | 7.03 Mn | -34.75% |
| 9 | MindWalk Holdings | 61.66 Mn | 53.38 Mn | 1.82 Mn | -8.48% |
| 10 | VivoSim Labs | 1.47 Mn | 1.47 Mn | - | -0.11% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1,000.00% |
| Mar 31, 2026 | -91.87% |
| Dec 31, 2025 | 8.71% |
| Sep 30, 2025 | 44.60% |
| Jun 30, 2025 | -1.13% |
| Mar 31, 2025 | -2.72% |
| Dec 31, 2024 | 1.34% |
| Sep 30, 2024 | 48.32% |
| Jun 30, 2024 | -12.08% |
| Mar 31, 2024 | -5.42% |
| Dec 31, 2023 | 11.15% |
| Sep 30, 2023 | 26.48% |
| Jun 30, 2023 | 31.69% |
| Mar 31, 2023 | 15.79% |
| Dec 31, 2022 | -63.86% |
| Sep 30, 2022 | 18.33% |
| Jun 30, 2022 | 20.57% |